1. Home
  2. TBLA vs NRIX Comparison

TBLA vs NRIX Comparison

Compare TBLA & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBLA
  • NRIX
  • Stock Information
  • Founded
  • TBLA 2007
  • NRIX 2009
  • Country
  • TBLA United States
  • NRIX United States
  • Employees
  • TBLA N/A
  • NRIX N/A
  • Industry
  • TBLA Computer Software: Programming Data Processing
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TBLA Technology
  • NRIX Health Care
  • Exchange
  • TBLA Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • TBLA 1.2B
  • NRIX 1.1B
  • IPO Year
  • TBLA N/A
  • NRIX 2020
  • Fundamental
  • Price
  • TBLA $2.84
  • NRIX $13.86
  • Analyst Decision
  • TBLA Strong Buy
  • NRIX Strong Buy
  • Analyst Count
  • TBLA 5
  • NRIX 16
  • Target Price
  • TBLA $5.05
  • NRIX $31.75
  • AVG Volume (30 Days)
  • TBLA 2.9M
  • NRIX 743.2K
  • Earning Date
  • TBLA 02-26-2025
  • NRIX 04-09-2025
  • Dividend Yield
  • TBLA N/A
  • NRIX N/A
  • EPS Growth
  • TBLA N/A
  • NRIX N/A
  • EPS
  • TBLA N/A
  • NRIX N/A
  • Revenue
  • TBLA $1,766,220,000.00
  • NRIX $54,549,000.00
  • Revenue This Year
  • TBLA $17.09
  • NRIX $1.77
  • Revenue Next Year
  • TBLA $14.31
  • NRIX $6.62
  • P/E Ratio
  • TBLA N/A
  • NRIX N/A
  • Revenue Growth
  • TBLA 22.68
  • NRIX N/A
  • 52 Week Low
  • TBLA $2.69
  • NRIX $11.90
  • 52 Week High
  • TBLA $4.67
  • NRIX $29.56
  • Technical
  • Relative Strength Index (RSI)
  • TBLA 30.28
  • NRIX 27.15
  • Support Level
  • TBLA $2.69
  • NRIX $13.54
  • Resistance Level
  • TBLA $3.10
  • NRIX $15.51
  • Average True Range (ATR)
  • TBLA 0.21
  • NRIX 1.00
  • MACD
  • TBLA -0.08
  • NRIX -0.22
  • Stochastic Oscillator
  • TBLA 11.64
  • NRIX 7.06

About TBLA Taboola.com Ltd.

Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, Germany, France, Rest of the world whilst it generates the majority of its revenue from the United States.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: